1. Home
  2. UXIN vs IVVD Comparison

UXIN vs IVVD Comparison

Compare UXIN & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uxin Limited ADS

UXIN

Uxin Limited ADS

HOLD

Current Price

$2.86

Market Cap

612.3M

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$2.23

Market Cap

692.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UXIN
IVVD
Founded
2011
2020
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
612.3M
692.7M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
UXIN
IVVD
Price
$2.86
$2.23
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.33
AVG Volume (30 Days)
83.2K
12.0M
Earning Date
09-23-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$340,011,237.00
$50,039,000.00
Revenue This Year
$727.65
$103.88
Revenue Next Year
N/A
$171.40
P/E Ratio
N/A
N/A
Revenue Growth
63.82
332.71
52 Week Low
$2.45
$0.35
52 Week High
$5.41
$3.07

Technical Indicators

Market Signals
Indicator
UXIN
IVVD
Relative Strength Index (RSI) 50.50 53.98
Support Level $2.56 $2.09
Resistance Level $3.08 $2.60
Average True Range (ATR) 0.24 0.22
MACD 0.04 -0.04
Stochastic Oscillator 62.90 17.86

Price Performance

Historical Comparison
UXIN
IVVD

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: